Skip to main content
Top
Published in: Journal of Cachexia, Sarcopenia and Muscle 2/2014

01-06-2014 | Original Article

Hypothalamic food intake regulation in a cancer-cachectic mouse model

Authors: Jvalini T. Dwarkasing, Miriam van Dijk, Francina J. Dijk, Mark V. Boekschoten, Joyce Faber, Josep M. Argilès, Alessandro Laviano, Michael Müller, Renger F. Witkamp, Klaske van Norren

Published in: Journal of Cachexia, Sarcopenia and Muscle | Issue 2/2014

Login to get access

Abstract

Background

Appetite is frequently affected in cancer patients leading to anorexia and consequently insufficient food intake. In this study, we report on hypothalamic gene expression profile of a cancer-cachectic mouse model with increased food intake. In this model, mice bearing C26 tumour have an increased food intake subsequently to the loss of body weight. We hypothesise that in this model, appetite-regulating systems in the hypothalamus, which apparently fail in anorexia, are still able to adapt adequately to changes in energy balance. Therefore, studying changes that occur on appetite regulators in the hypothalamus might reveal targets for treatment of cancer-induced eating disorders. By applying transcriptomics, many appetite-regulating systems in the hypothalamus could be taken into account, providing an overview of changes that occur in the hypothalamus during tumour growth.

Methods

C26-colon adenocarcinoma cells were subcutaneously inoculated in 6 weeks old male CDF1 mice. Body weight and food intake were measured three times a week. On day 20, hypothalamus was dissected and used for transcriptomics using Affymetrix chips.

Results

Food intake increased significantly in cachectic tumour-bearing mice (TB), synchronously to the loss of body weight. Hypothalamic gene expression of orexigenic neuropeptides NPY and AgRP was higher, whereas expression of anorexigenic genes CCK and POMC were lower in TB compared to controls.
In addition, serotonin and dopamine signalling pathways were found to be significantly altered in TB mice. Serotonin levels in brain showed to be lower in TB mice compared to control mice, while dopamine levels did not change. Moreover, serotonin levels inversely correlated with food intake.

Conclusions

Transcriptomic analysis of the hypothalamus of cachectic TB mice with an increased food intake showed changes in NPY, AgRP and serotonin signalling. Serotonin levels in the brain showed to correlate with changes in food intake. Further research has to reveal whether targeting these systems will be a good strategy to avoid the development of cancer-induced eating disorders.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef
3.
go back to reference Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381:415–21.PubMedCrossRef Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381:415–21.PubMedCrossRef
4.
go back to reference Qian S et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22:5027–35.PubMedCentralPubMedCrossRef Qian S et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22:5027–35.PubMedCentralPubMedCrossRef
6.
go back to reference Laviano A et al. NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition. 2008;24:802–5.PubMedCrossRef Laviano A et al. NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition. 2008;24:802–5.PubMedCrossRef
7.
go back to reference van Norren K et al. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100:713–22.PubMedCentralPubMedCrossRef van Norren K et al. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100:713–22.PubMedCentralPubMedCrossRef
8.
go back to reference van Eijk HM, Rooyakkers DR, Deutz NE. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2–3 microns Spherisorb ODS II column. J Chromatogr. 1993;620:143–8.PubMedCrossRef van Eijk HM, Rooyakkers DR, Deutz NE. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2–3 microns Spherisorb ODS II column. J Chromatogr. 1993;620:143–8.PubMedCrossRef
9.
go back to reference Lin K et al. MADMAX—management and analysis database for multiple omics experiments. J Integr Bioinform. 2011;8:160.PubMed Lin K et al. MADMAX—management and analysis database for multiple omics experiments. J Integr Bioinform. 2011;8:160.PubMed
12.
go back to reference Bolstad BM et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–93.PubMedCrossRef Bolstad BM et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–93.PubMedCrossRef
13.
go back to reference Sartor MA et al. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinforma. 2006;7:538.CrossRef Sartor MA et al. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinforma. 2006;7:538.CrossRef
16.
go back to reference Tomita T, Kimura S. Regulation of mouse Scgb3a1 gene expression by NF-Y and association of CpG methylation with its tissue-specific expression. BMC Mol Biol. 2008;9:5.PubMedCentralPubMedCrossRef Tomita T, Kimura S. Regulation of mouse Scgb3a1 gene expression by NF-Y and association of CpG methylation with its tissue-specific expression. BMC Mol Biol. 2008;9:5.PubMedCentralPubMedCrossRef
17.
go back to reference Ding M, Toth LA. mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol Genomics. 2006;24:225–34.PubMedCrossRef Ding M, Toth LA. mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol Genomics. 2006;24:225–34.PubMedCrossRef
18.
go back to reference Tanaka Y et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990;50:2290–5.PubMed Tanaka Y et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990;50:2290–5.PubMed
19.
go back to reference Iizuka N et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer. 2002;99:286–91.PubMedCrossRef Iizuka N et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer. 2002;99:286–91.PubMedCrossRef
20.
go back to reference Soda K et al. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer J Int du Cancer. 1995;62:332–6.CrossRef Soda K et al. Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer J Int du Cancer. 1995;62:332–6.CrossRef
21.
22.
go back to reference Murphy KT, et al. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 2012;5:533–45. Murphy KT, et al. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 2012;5:533–45.
23.
go back to reference Aulino P et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363.PubMedCentralPubMedCrossRef Aulino P et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363.PubMedCentralPubMedCrossRef
24.
go back to reference Sacchi A, Mauro F, Zupi G. Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth. Clin Exp Metastasis. 1984;2:171–8.PubMedCrossRef Sacchi A, Mauro F, Zupi G. Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growth. Clin Exp Metastasis. 1984;2:171–8.PubMedCrossRef
25.
go back to reference Faber J et al. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer. 2008;99:2029–36.PubMedCentralPubMedCrossRef Faber J et al. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer. 2008;99:2029–36.PubMedCentralPubMedCrossRef
26.
go back to reference Sonti G, Ilyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol. 1996;270:R1394–402.PubMed Sonti G, Ilyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol. 1996;270:R1394–402.PubMed
27.
go back to reference Rothman RB et al. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse. 2003;50:233–9.PubMedCrossRef Rothman RB et al. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse. 2003;50:233–9.PubMedCrossRef
28.
29.
go back to reference Meguid MM et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides. 2004;25:261–6.PubMedCrossRef Meguid MM et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides. 2004;25:261–6.PubMedCrossRef
30.
go back to reference Salamone JD, Correa M. Dopamine and food addiction: lexicon badly needed. Biol Psychiatry. 2012;73:e15–24. Salamone JD, Correa M. Dopamine and food addiction: lexicon badly needed. Biol Psychiatry. 2012;73:e15–24.
31.
go back to reference Meguid MM, Yang ZJ, Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull. 1995;36:487–90.PubMedCrossRef Meguid MM, Yang ZJ, Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull. 1995;36:487–90.PubMedCrossRef
32.
go back to reference Sato T et al. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1907–16.PubMed Sato T et al. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1907–16.PubMed
33.
go back to reference Lozano RH, Jofre IS. Novel use of L-dOPA in the treatment of anorexia and asthenia associated with cancer. Palliat Med. 2002;16:548.PubMedCrossRef Lozano RH, Jofre IS. Novel use of L-dOPA in the treatment of anorexia and asthenia associated with cancer. Palliat Med. 2002;16:548.PubMedCrossRef
35.
go back to reference Ratner C, et al. Cerebral markers of the serotonergic system in rat models of obesity and after roux-en-Y gastric bypass. Obesity (Silver Spring). 2012;20:2133–41. Ratner C, et al. Cerebral markers of the serotonergic system in rat models of obesity and after roux-en-Y gastric bypass. Obesity (Silver Spring). 2012;20:2133–41.
36.
go back to reference Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3:477S–80S.PubMedCrossRef Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3:477S–80S.PubMedCrossRef
37.
go back to reference Madras BK et al. Elevation of serum free tryptophan, but not brain tryptophan, by serum nonesterified fatty acids. Adv Biochem Psychopharmacol. 1974;11:143–51.PubMed Madras BK et al. Elevation of serum free tryptophan, but not brain tryptophan, by serum nonesterified fatty acids. Adv Biochem Psychopharmacol. 1974;11:143–51.PubMed
38.
go back to reference Molfino A et al. Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia. Pharmacol Biochem Behav. 2008;89:31–5.PubMedCrossRef Molfino A et al. Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia. Pharmacol Biochem Behav. 2008;89:31–5.PubMedCrossRef
39.
go back to reference Sato T et al. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia. Clin Nutr. 2003;22:139–46.PubMedCrossRef Sato T et al. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia. Clin Nutr. 2003;22:139–46.PubMedCrossRef
40.
go back to reference Bossola M et al. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients. J Ren Nutr. 2009;19:248–55.PubMedCrossRef Bossola M et al. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients. J Ren Nutr. 2009;19:248–55.PubMedCrossRef
41.
go back to reference Koren MS et al. Changes in plasma amino acid levels do not predict satiety and weight loss on diets with modified macronutrient composition. Ann Nutr Metab. 2007;51:182–7.PubMedCrossRef Koren MS et al. Changes in plasma amino acid levels do not predict satiety and weight loss on diets with modified macronutrient composition. Ann Nutr Metab. 2007;51:182–7.PubMedCrossRef
42.
go back to reference Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.PubMedCentralPubMedCrossRef Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.PubMedCentralPubMedCrossRef
43.
go back to reference Argiles JM et al. Catabolic mediators as targets for cancer cachexia. Drug Discov Today. 2003;8:838–44.PubMedCrossRef Argiles JM et al. Catabolic mediators as targets for cancer cachexia. Drug Discov Today. 2003;8:838–44.PubMedCrossRef
44.
go back to reference Asp ML et al. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756–63.PubMedCrossRef Asp ML et al. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756–63.PubMedCrossRef
45.
go back to reference Joppa MA et al. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides. 2007;28:636–42.PubMedCrossRef Joppa MA et al. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides. 2007;28:636–42.PubMedCrossRef
46.
go back to reference Chance WT et al. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Peptides. 2007;28:295–301.PubMedCrossRef Chance WT et al. Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats. Peptides. 2007;28:295–301.PubMedCrossRef
47.
go back to reference Nara-ashizawa N et al. Response of hypothalamic NPY mRNAs to a negative energy balance is less sensitive in cachectic mice bearing human tumor cells. Nutr Cancer. 2001;41:111–8.PubMedCrossRef Nara-ashizawa N et al. Response of hypothalamic NPY mRNAs to a negative energy balance is less sensitive in cachectic mice bearing human tumor cells. Nutr Cancer. 2001;41:111–8.PubMedCrossRef
48.
go back to reference Dryden S et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res. 1996;724:232–7.PubMedCrossRef Dryden S et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res. 1996;724:232–7.PubMedCrossRef
49.
go back to reference Shinozaki T et al. Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats. Biol Pharm Bull. 2008;31:2250–4.PubMedCrossRef Shinozaki T et al. Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats. Biol Pharm Bull. 2008;31:2250–4.PubMedCrossRef
Metadata
Title
Hypothalamic food intake regulation in a cancer-cachectic mouse model
Authors
Jvalini T. Dwarkasing
Miriam van Dijk
Francina J. Dijk
Mark V. Boekschoten
Joyce Faber
Josep M. Argilès
Alessandro Laviano
Michael Müller
Renger F. Witkamp
Klaske van Norren
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cachexia, Sarcopenia and Muscle / Issue 2/2014
Print ISSN: 2190-5991
Electronic ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-013-0121-y

Other articles of this Issue 2/2014

Journal of Cachexia, Sarcopenia and Muscle 2/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.